Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:cysteamine_bitartrate
|
| gptkbp:alternativeTo |
gptkb:Procysbi
|
| gptkbp:approvalYear |
1994
|
| gptkbp:ATCCode |
A16AA04
|
| gptkbp:contraindication |
hypersensitivity to cysteamine
|
| gptkbp:form |
capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cystagon
|
| gptkbp:indication |
gptkb:nephropathic_cystinosis
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Recordati_Rare_Diseases
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea abdominal pain lethargy |
| gptkbp:storage |
room temperature
|
| gptkbp:usedFor |
reducing cystine accumulation
|
| gptkbp:bfsParent |
gptkb:Recordati
|
| gptkbp:bfsLayer |
7
|